色中色直播

The Makers of Prevagen

色中色直播 is a biotechnology company focused on the discovery, development, and commercialization of novel technologies for your brain.*

Learn More >

Innovation

色中色直播 is set apart by its cutting-edge applications of the ingredient apoaequorin.

Quality

色中色直播 has built a culture of quality. We are fully compliant to government standards and certified by NSF International, a 3rd party auditing firm for manufacturing and quality control practices.

Products

The Prevagen brand line-up of products represents best-in-class over-the-counter dietary supplements.

COMPANY

Core Values

No company is a single entity. It is comprised of a collection of individuals from a variety of disciplines with unique skill sets who are bonded together by a common commitment and held together by shared values that create lasting success to serve the needs of our customers.

Work With Us

Confidence

Respect

Teamwork

Excellence

Culture

Integrity

News

Press Release

Today the FTC released a statement regarding a ruling by the U.S. District Court for the Southern District of New York in its case (along with the New York Attorney General) against 色中色直播. Notably, the FTC's statement did not refer to the portion of the Judge's order that once again confirmed the jury's findings that the principal claims for Prevagen (e.g., Prevagen improves memory," "Prevagen is clinically shown to improve memory within 90 days," and Prevagen provides other cognitive benefits, including but not limited to healthy brain function, a sharper mind, and clearer thinking," etc.) are not materially misleading.

The statement also neglected to refer to the Judge's findings that there was "no intent to harm" - an indication of his belief that the Company has acted in good faith - nor did it refer to his rejection of the NYAG's efforts to obtain statutory penalties, disgorgement and/or statutory costs. And of course, there has never been a health issue here - no one is disputing that Prevagen庐 is safe.

The order merely requires certain changes to Quincy's advertising on a going forward basis. While we strongly believe this requirement is based on a misreading of the law and science supporting the advertising statements, and will appeal the Judge's decision, Quincy has already started to transition its marketing campaign for Prevagen. We are pleased that the judge clarified-as we requested-that the Company will be afforded a reasonable amount of time to launch its new advertising.

The Company is excited about the upcoming launch of its refreshed Prevagen branding and is pleased that it will be able to continue to market Prevagen in the U.S. - bringing a gold-standard supplement to every state in the country.